<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02928692</url>
  </required_header>
  <id_info>
    <org_study_id>20158202</org_study_id>
    <nct_id>NCT02928692</nct_id>
  </id_info>
  <brief_title>Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium</brief_title>
  <acronym>MAPOCD</acronym>
  <official_title>Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium: A Multicenter, Randomized, Double-Blind Clinical Trail</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shanghai 10th People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pudong New Area People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Pudong Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Pudong New Aera Dongming Community Health Care Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>RenJi Hospital</source>
  <brief_summary>
    <textblock>
      Postoperative cognitive dysfunction (POCD) and postoperative delirium occurs mainly in aged
      patients. POCD and POD may increase the mortality and morbidity. However, the mechanism of
      POCD is not clear yet and no effective therapy method was proved. According to previous
      study, the neuroinflammation is the main reason both for POCD and POD. Minocycline is a
      tetracycline derivative. Due to it's lipophilic structure, it is easy to pass through blood
      brain barrier and attenuate neuroinflammation. It's neuroprotective effects has been proven
      in many experimental animal models such as Alzheimer's disease, Huntington's disease and
      Parkinson's syndrome. In present study, the investigators hypothesized that minocycline would
      attenuate the incidence of POCD and POD in the aged patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>POCD incidence 7 days (or before leaving hospital) after surgery</measure>
    <time_frame>7 days (or before leaving hospital)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>POD incidence</measure>
    <time_frame>1 to 5 days after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>POCD incidence 2 months after surgery</measure>
    <time_frame>2 months after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">750</enrollment>
  <condition>Prostate Cancer</condition>
  <condition>Carcinoma of the Rectum</condition>
  <condition>Colon Cancer</condition>
  <condition>Renal Carcinoma</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo administered before surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Minocycline</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Minocycline was administrated before surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Volunteers</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Health people for calculate the incidence of POCD</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Minocycline</intervention_name>
    <arm_group_label>Minocycline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        For the placebo and minocycline group;

        Inclusion Criteria:

          1. Elder than 65 years old

          2. Speak Chinese Mandarin

          3. Those who will undergo major general surgery like colorectal cancer excision, major
             urinary surgery like radical prostatectomy and radical nephrectomy

          4. Signed the inform consent

          5. American Society of Anesthesiologists classification I to III

        Exclusion Criteria:

          1. Existing cerebral disease, or have a history of neurological and psychiatric diseases
             including Alzheimer Disease, stroke, epilepsy and psychosis;

          2. Existing cognitive impairment as evidenced by Mini-Mental State Examination scores
             below 24;

          3. Severe audition or vision disorder;

          4. Unwillingness to comply with the protocol or procedures.

          5. Cannot communicated with Chinese Mandarin

          6. With severe skin disease

          7. Serious heart or liver or renal insufficiency patients

          8. Had surgery in the past 30 days

          9. Allergy to tetracycline or minocycline

        For the health volunteers;

        Inclusion Criteria:

          1. Elder than 65 years old

          2. Speak Chinese Mandarin

          3. Signed the inform consent

          4. No major disease health people

        Exclusion Criteria:

          1. Existing cerebral disease, or have a history of neurological and psychiatric diseases
             including Alzheimer Disease, stroke, epilepsy and psychosis;

          2. Existing cognitive impairment as evidenced by Mini-Mental State Examination scores
             below 24;

          3. Severe audition or vision disorder;

          4. Unwillingness to comply with the protocol or procedures.

          5. Cannot communicated with Chinese Mandarin

          6. Drug abuse, alcoholism

          7. Serious heart or liver or renal insufficiency patients

          8. Had surgery in the past 30 days

          9. Plan to undergo surgery in the following 3 months.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Diansan Su, Doctor</last_name>
    <phone>18616514088</phone>
    <email>diansansu@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hui Li, Master Degree Candidate</last_name>
    <phone>15216711923</phone>
    <email>56428923@qq.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Scales</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200127</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diansan Su, Dr.</last_name>
      <phone>18616514088</phone>
      <email>diansansu@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Hui Li, M.S.</last_name>
      <phone>15216711923</phone>
      <email>56428923@qq.com</email>
    </contact_backup>
    <investigator>
      <last_name>Diansan Su, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hui Li, M.S.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shanghai Pudong Hospital</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hongwei Duan</last_name>
      <phone>189-1879-0035</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shanghai Pudong New Area Dongming Community Health Care Center</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shifen Zhang</last_name>
      <phone>13916517543</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shanghai Pudong New Area people's Hopsital</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lizhi Li, M.D.</last_name>
      <phone>139-1768-2738</phone>
      <email>Fmlilizhi@sina.com.cn</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shanghai Tenth Hospital</name>
      <address>
        <city>Shanghai</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shukun Fu, M.D.</last_name>
      <phone>13816343916</phone>
      <email>shukunfu@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Large MC, Reichard C, Williams JT, Chang C, Prasad S, Leung Y, DuBeau C, Bales GT, Steinberg GD. Incidence, risk factors, and complications of postoperative delirium in elderly patients undergoing radical cystectomy. Urology. 2013 Jan;81(1):123-8. doi: 10.1016/j.urology.2012.07.086. Epub 2012 Nov 13.</citation>
    <PMID>23153950</PMID>
  </reference>
  <reference>
    <citation>Pol RA, van Leeuwen BL, Izaks GJ, Reijnen MM, Visser L, Tielliu IF, Zeebregts CJ. C-reactive protein predicts postoperative delirium following vascular surgery. Ann Vasc Surg. 2014 Nov;28(8):1923-30. doi: 10.1016/j.avsg.2014.07.004. Epub 2014 Jul 10.</citation>
    <PMID>25017770</PMID>
  </reference>
  <reference>
    <citation>Nadelson MR, Sanders RD, Avidan MS. Perioperative cognitive trajectory in adults. Br J Anaesth. 2014 Mar;112(3):440-51. doi: 10.1093/bja/aet420. Epub 2014 Jan 2. Review.</citation>
    <PMID>24384981</PMID>
  </reference>
  <reference>
    <citation>Westhoff D, Witlox J, Koenderman L, Kalisvaart KJ, de Jonghe JF, van Stijn MF, Houdijk AP, Hoogland IC, Maclullich AM, van Westerloo DJ, van de Beek D, Eikelenboom P, van Gool WA. Preoperative cerebrospinal fluid cytokine levels and the risk of postoperative delirium in elderly hip fracture patients. J Neuroinflammation. 2013 Oct 7;10:122. doi: 10.1186/1742-2094-10-122.</citation>
    <PMID>24093540</PMID>
  </reference>
  <reference>
    <citation>Shim JJ, Leung JM. An update on delirium in the postoperative setting: prevention, diagnosis and management. Best Pract Res Clin Anaesthesiol. 2012 Sep;26(3):327-43. doi: 10.1016/j.bpa.2012.08.003. Review.</citation>
    <PMID>23040284</PMID>
  </reference>
  <reference>
    <citation>van Meenen LC, van Meenen DM, de Rooij SE, ter Riet G. Risk prediction models for postoperative delirium: a systematic review and meta-analysis. J Am Geriatr Soc. 2014 Dec;62(12):2383-90. doi: 10.1111/jgs.13138. Review.</citation>
    <PMID>25516034</PMID>
  </reference>
  <reference>
    <citation>American Geriatrics Society Expert Panel on Postoperative Delirium in Older Adults. Postoperative delirium in older adults: best practice statement from the American Geriatrics Society. J Am Coll Surg. 2015 Feb;220(2):136-48.e1. doi: 10.1016/j.jamcollsurg.2014.10.019. Epub 2014 Nov 14.</citation>
    <PMID>25535170</PMID>
  </reference>
  <reference>
    <citation>Bellelli G, Mazzola P, Morandi A, Bruni A, Carnevali L, Corsi M, Zatti G, Zambon A, Corrao G, Olofsson B, Gustafson Y, Annoni G. Duration of postoperative delirium is an independent predictor of 6-month mortality in older adults after hip fracture. J Am Geriatr Soc. 2014 Jul;62(7):1335-40. doi: 10.1111/jgs.12885. Epub 2014 Jun 2.</citation>
    <PMID>24890941</PMID>
  </reference>
  <reference>
    <citation>Ramaiah R, Lam AM. Postoperative cognitive dysfunction in the elderly. Anesthesiol Clin. 2009 Sep;27(3):485-96, table of contents. doi: 10.1016/j.anclin.2009.07.011. Review.</citation>
    <PMID>19825488</PMID>
  </reference>
  <reference>
    <citation>Sauër AM, Kalkman C, van Dijk D. Postoperative cognitive decline. J Anesth. 2009;23(2):256-9. doi: 10.1007/s00540-009-0744-5. Epub 2009 May 15. Review.</citation>
    <PMID>19444566</PMID>
  </reference>
  <reference>
    <citation>Moller JT, Cluitmans P, Rasmussen LS, Houx P, Rasmussen H, Canet J, Rabbitt P, Jolles J, Larsen K, Hanning CD, Langeron O, Johnson T, Lauven PM, Kristensen PA, Biedler A, van Beem H, Fraidakis O, Silverstein JH, Beneken JE, Gravenstein JS. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet. 1998 Mar 21;351(9106):857-61. Erratum in: Lancet 1998 Jun 6;351(9117):1742.</citation>
    <PMID>9525362</PMID>
  </reference>
  <reference>
    <citation>Monk TG, Weldon BC, Garvan CW, Dede DE, van der Aa MT, Heilman KM, Gravenstein JS. Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology. 2008 Jan;108(1):18-30.</citation>
    <PMID>18156878</PMID>
  </reference>
  <reference>
    <citation>Steinmetz J, Christensen KB, Lund T, Lohse N, Rasmussen LS; ISPOCD Group. Long-term consequences of postoperative cognitive dysfunction. Anesthesiology. 2009 Mar;110(3):548-55. doi: 10.1097/ALN.0b013e318195b569.</citation>
    <PMID>19225398</PMID>
  </reference>
  <reference>
    <citation>Vacas S, Degos V, Feng X, Maze M. The neuroinflammatory response of postoperative cognitive decline. Br Med Bull. 2013;106:161-78. doi: 10.1093/bmb/ldt006. Epub 2013 Apr 4. Review.</citation>
    <PMID>23558082</PMID>
  </reference>
  <reference>
    <citation>Wan Y, Xu J, Ma D, Zeng Y, Cibelli M, Maze M. Postoperative impairment of cognitive function in rats: a possible role for cytokine-mediated inflammation in the hippocampus. Anesthesiology. 2007 Mar;106(3):436-43.</citation>
    <PMID>17325501</PMID>
  </reference>
  <reference>
    <citation>Fidalgo AR, Cibelli M, White JP, Nagy I, Maze M, Ma D. Systemic inflammation enhances surgery-induced cognitive dysfunction in mice. Neurosci Lett. 2011 Jul 1;498(1):63-6. doi: 10.1016/j.neulet.2011.04.063. Epub 2011 May 6.</citation>
    <PMID>21575676</PMID>
  </reference>
  <reference>
    <citation>Cibelli M, Fidalgo AR, Terrando N, Ma D, Monaco C, Feldmann M, Takata M, Lever IJ, Nanchahal J, Fanselow MS, Maze M. Role of interleukin-1beta in postoperative cognitive dysfunction. Ann Neurol. 2010 Sep;68(3):360-8. doi: 10.1002/ana.22082.</citation>
    <PMID>20818791</PMID>
  </reference>
  <reference>
    <citation>Terrando N, Eriksson LI, Ryu JK, Yang T, Monaco C, Feldmann M, Jonsson Fagerlund M, Charo IF, Akassoglou K, Maze M. Resolving postoperative neuroinflammation and cognitive decline. Ann Neurol. 2011 Dec;70(6):986-995. doi: 10.1002/ana.22664.</citation>
    <PMID>22190370</PMID>
  </reference>
  <reference>
    <citation>Vacas S, Degos V, Tracey KJ, Maze M. High-mobility group box 1 protein initiates postoperative cognitive decline by engaging bone marrow-derived macrophages. Anesthesiology. 2014 May;120(5):1160-7. doi: 10.1097/ALN.0000000000000045.</citation>
    <PMID>24162463</PMID>
  </reference>
  <reference>
    <citation>Wan Y, Xu J, Meng F, Bao Y, Ge Y, Lobo N, Vizcaychipi MP, Zhang D, Gentleman SM, Maze M, Ma D. Cognitive decline following major surgery is associated with gliosis, β-amyloid accumulation, and τ phosphorylation in old mice. Crit Care Med. 2010 Nov;38(11):2190-8. doi: 10.1097/CCM.0b013e3181f17bcb.</citation>
    <PMID>20711073</PMID>
  </reference>
  <reference>
    <citation>Su X, Feng X, Terrando N, Yan Y, Chawla A, Koch LG, Britton SL, Matthay MA, Maze M. Dysfunction of inflammation-resolving pathways is associated with exaggerated postoperative cognitive decline in a rat model of the metabolic syndrome. Mol Med. 2013 Feb 8;18:1481-90. doi: 10.2119/molmed.2012.00351.</citation>
    <PMID>23296426</PMID>
  </reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 5, 2016</study_first_submitted>
  <study_first_submitted_qc>October 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 10, 2016</study_first_posted>
  <last_update_submitted>October 6, 2016</last_update_submitted>
  <last_update_submitted_qc>October 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 10, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>RenJi Hospital</investigator_affiliation>
    <investigator_full_name>diansan su</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>Minocycline</keyword>
  <keyword>Postoperative cognitive dysfunction</keyword>
  <keyword>Postoperative delirium</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
    <mesh_term>Carcinoma, Renal Cell</mesh_term>
    <mesh_term>Kidney Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Minocycline</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

